Our single objective: to prevent and reverse disability for everyone with multiple sclerosis, neuromyelitis optica and MOG associated disease.

Research Themes

Cambridge Clinical Multiple Sclerosis Research Group is achieving this objective through six themes:

Personalising Treatments through Big Data and AI
Discovering and Proving New Repair therapies
Our Visual and MRI Outcome Development Program
Studying Children with MS, NMO and related conditions
Study ageing in multiple sclerosis
Measuring and sustainably addressing healthcare inequalities.

Currently our work is focused on:

Improving the availability of data in electonic health records in the UK for MS researchers
Using real-world data to answer important questions about how best to use MS therapies
Exploring how best to measure remyelination in adults and children with MS
Investigating natural remyelination in people with MS
Doing clinical trials to identify drugs which promote endogenous remyelination in people with MS

Featured News

Dr Chris McMurran Delivers an Opening Plenary Lecture at the MS Trust Annual Conference 2026

24th March 2026

A proud moment for our team as Ageing and Brain Health Group Lead, Dr Chris McMurran, was invited to deliver an opening plenary lecture at the MS Trust Annual Conference.

Read more here.

Review Published in Brain on the Link Between Ageing and Remyelination

5th January 2026

Our review on the link between ageing and remyelination has been published in Brain. Click through to learn more about the key takeaway messages and access the full article.

Read more here.

Publication of CCMR Two Protocol

19th December 2025

The protocol for the CCMR Two trial has now been published and can be access via the link included on our News page.

Access it here.